Australia markets closed

Crinetics Pharmaceuticals, Inc. (CRNX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
51.66+2.16 (+4.36%)
As of 09:43AM EDT. Market open.
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
54,897
32,672
200,695
93,087
-
Other short-term investments
503,658
301,753
133,012
77,793
-
Total cash
558,555
334,425
333,707
170,880
-
Other current assets
1,578
1,930
912
1,024
-
Total current assets
574,153
345,184
344,720
177,492
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
62,498
9,070
8,197
7,971
-
Accumulated depreciation
-5,068
-4,084
-3,480
-2,558
-
Net property, plant and equipment
57,430
4,986
4,717
5,413
-
Equity and other investments
470
0
1,010
0
-
Other long-term assets
3,300
1,338
500
540
-
Total non-current assets
61,200
6,992
6,295
5,953
-
Total assets
635,353
352,176
351,015
183,445
-
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
6,548
6,883
3,422
3,488
-
Accrued liabilities
16,648
8,468
5,046
2,100
-
Deferred revenues
2,056
2,240
0
-
-
Other current liabilities
-
1,051
939
835
724
Total current liabilities
43,942
27,723
15,995
10,489
-
Non-current liabilities
Deferred revenues
4,750
6,101
0
-
-
Other long-term liabilities
-
-
2
23
49
Total non-current liabilities
52,305
8,125
3,076
4,037
-
Total liabilities
96,247
35,848
19,071
14,526
-
Stockholders' equity
Common stock
1,191,831
759,432
607,581
336,508
-
Retained earnings
-653,702
-439,173
-275,255
-167,614
-
Accumulated other comprehensive income
977
-3,931
-382
25
-
Total stockholders' equity
539,106
316,328
331,944
168,919
-
Total liabilities and stockholders' equity
635,353
352,176
351,015
183,445
-